Biotechnology the agricultural sector of India. India is among the top 12 biotech destinations in the world and is the largest producer of recombinant Hepatitis B vaccine. Out of the top 10 biotech companies in India (by revenue), six focus their expertise in biopharmaceuticals and four specialize in Agri-biotech. India had recently overtaken Canada to emerge as the fourth largest country to grow biotech or genetically modified (GM) crops, as farmers were planting Bt cotton in about 11 million hectares. The global acreages under GM crops increased to 175.2 million hectares in 2013, about five million hectares more than the previous year.
India also has no dearth of talent in this sector, as a number of institutions, both government and autonomy, provide the necessary opportunities for the student seeking to obtain a degree in this sector. Also, the Government of India has provided adequate scope to this sector by providing facilities for research and development in the field of biotechnology.
Market size of Indian biotechnology sector:-
The total industry size was US$ 4.3 billion at the end of FY13.
Market break-up of Indian biotechnology industry.
The biopharmaceutical segment accounted for the largest share of the biotech industry, with 64.0 percent of total revenues in FY13.
Exports of biotechnology products from India.
Between FY05 and FY13, revenue from exports increased at a CAGR of 25.1 percent to US$ 2.2 billion.
Exports of biotechnology products from India.
Between FY05 and FY13, revenue from exports increased at a CAGR of 25.1 percent to US$ 2.2 billion.
A few days ago our Prime Minister, while addressing the US-Americans make up the platform of India through India have committed to grooming. To fulfill the promise of Prime Minister Modi 25 'Lion' will play an important role. These lions are considered very important in their place. In these 25lion. 1 lion is Biotechnology for our Prime Minister Modi, which is useful for youth and those who related to this field is to understand and think of it.
In the Asia region, India has the third largest biotech industry. USFDA approved, the second highest of the plant have been planted here. Biotechnology sector spent $3.7 billion in the year 2012-17 to the plan. Hepatitis B vaccine is made the highest in India. 2013 bio-Economy rage has reached a level of $ 4.3 billion. By 2025 it will be $ 100 billion industry. Yet in this area, the United States, France and Singapore are investing in India. Seven of these countries is investing in biotechnology companies in India.
